In this week’s View, Dr. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure ...

Medical therapy is critical in preventing the worst complications of peripheral artery disease (PAD), among them heart attack ...

The U.S. Food and Drug Administration (FDA) has approved acoramidis as a treatment to help reduce cardiovascular death and cardiovascular-related hospitalization in patients with transthyretin amyloid ...

This handbook is intended for all of those involved with treating patients with structural heart disease. In developing this resource, our goal was to provide a single source of introductory ...

Together, we rise to the challenges of today. We share knowledge and identify real solutions for tomorrow. And with dedicated clinicians and partners like you, we are advancing heart care worldwide, ...

The following are key points to remember from a review on national- and state-level prevalence of overweight and obesity among children, adolescents, and adults in the United States (US), 1990–2021, ...

The ACC Prevention of Cardiovascular Disease Section was created in March 2014 and emerged from the original ACC Prevention Committee when it became clear that cardiovascular disease (CVD) prevention, ...

In this interview, Thomas H. Marwick, MD, PhD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Takeaways from 2024 in Cardiovascular (CV) Imaging. Dr. Marwick discusses the SCOT-HEART trial, ...

The following are key points to remember from a 2024 updated international consensus statement on platelet function and genetic testing in percutaneous coronary intervention (PCI): ...

This page features ACC's full meeting coverage of the latest science from ACC.24 – including trial summaries, news stories, journal scans, videos and more.

This page features scientific coverage from ACC.20/WCC – including Expert Analyses, Patient Case Quizzes, Summary Slides, and Visual Abstracts. This post-meeting content was developed by the ACC.org ...

Cardiovascular disease (CVD) is the leading cause of pregnancy-related maternal death in the United States, driven by rising rates of hypertension, diabetes mellitus (DM), obesity, smoking, and ...